Pseudomonas aeruginosa antigens as potential vaccines

FEMS Microbiology Reviews

Volumn 21, Issue 3, 1997, Pages 243-277

  Stanislavsky, Eugene S ^a   Lam, Joseph S ^b  

^a MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

A band; B band; Cell wall; Common antigen; Core oligosaccharide; Lipid A; Lipopolysaccharide; Outer membrane; Pseudomonas aeruginosa; Vaccine

Indexed keywords

ANTIGEN; LIPID A; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDE; PSEUDOMONAS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGENICITY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031458161     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(97)00059-4     Document Type: Article

References (234)

1. Pseudomonadaceae (1977) In: The Shorter Bergey's Manual of Determinative Bacteriology (Holt, J., Ed.), pp. 77-82. Williams and Wilkins, Baltimore, MD.
2. Stanislavsky, E.S. and Kolker, I.I. (1978) Pyocyanic Infection. All-Union Research Institute for Medical and Medico-Technical Information, Moscow (in Russian).
3. Stanislavsky, E.S. (1980) Immunoprophylaxis and immunotherapy of diseases caused by Gram-negative bacteria. A review. Zh. Microbiol. Epidemiol. Immunobiol. 12, 91-96 (in Russian, abstract in English).
4. Emori, T.G. and Gaynes, R.P. (1993) An overview of nosocomial infection, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6, 428-442.
5. Hughes, J.M., Culver, D.H., White, J.W., Jarvis, W.R., Morgan, W.M., van Munn, P., Mosser, L.J. and Emori, T.G. (1983) Nosocomial Infection. Surveillance, 1980-1982. US Department of Health and Human Services, Centers for Diseases, November, Vol. 32, No. 4SS.
6. Pruitt, B.A. Jr., Lindberg, R.B., McManus, W.F. and Mason, A.D. Jr. (1983) Current approach to prevention and treatment of Pseudomonas aeruginosa infections in burned patients. Rev. Infect. Dis. 5 (Suppl. 5), S889-S897.
7. Lam, J., Chan, R., Lam, K. and Costerton, J.W. (1980) The production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28, 546-556.
8. Govan, J.R.W. and Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539-574.
9. Lanyi, B. and Bergan, T. (1978) Serological characterization of Pseudomonas aeruginosa. In: Methods in Microbiology (Bergan, T. and Norris, J.R., Eds.) Vol. 10, pp. 93-168. Academic Press, London.
10. Palleroni, N.J. (1984) Pseudomonas. In: Bergey's Manual of Systematic Bacteriology (Kreig, N.R. and Holt, J.G., Eds.), Vol. 1, pp. 141-198. Williams and Wilkins, Baltimore, MD.
11. Hancock, R.E. and Woodruff, W.A. (1988) Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa. Rev. Infect. Dis. 10, 770-775.
12. Poole, K., Krebes, K., McNally, C. and Neshat, S. (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175, 7363-7372.
13. Mogi, T., Fukuchi, K., Chen, G., Wakuta, R., Takagi, T., Takagi, Y. and Gomi, K. (1996) Multi-drug resistance of serovar E strains in clinically isolated Pseudomonas aeruginosa and analysis of genome pattern. Rinsho Byori 44, 147-152.
14. Li, X.Z., Nikaido, H. and Poole, K. (1995) Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 1948-1953.
15. Poole, K., Gotoh, N., Tsujimoto, H., Zaho, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J. and Nishino, T. (1996) Overexpression of the mexC-mexD-orpJ operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21, 713-724.
16. Köhler, T., Michéa-Hamzephpour, M., Henze, U., Gotoh, N., Curty, L.K. and Pechère, J.-C. (1997) Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23, 345-354.
17. Stanislavsky, E.S., Dmitriev, B.A., Lanyi, B. and Joo, I. (1985) Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy. A review. Acta Microbiol. Hung. 32, 3-37.
18. Winkler, U., Wingender, J. and Jager, K.E. (1985) Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis. Klin. Wochenschr. 63, 490-49 (in German).
19. Granstrom, M., Ericsson, A., Strandvik, B., Wretlind, B., Pavlovskis, O.R., Berka, R. and Vasil, M.L. (1984) Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr. Scand. 73, 772-777.
20. Gilleland, H.E., Gilleland, L.B. and Fowler, M.R. (1993) Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model. J. Med. Microbiol. 38, 79-86.
21. Granstrom, M., Wretlind, B., Markman, B., Pavlovskis, O.R. and Vasil, M.L. (1985) Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins. Eur. J. Clin. Microbiol. 4, 197-200.
22. Preston, M.J., Berk, J.M., Hazlett, L.D. and Berk, R.S. (1991) Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection. Infect. Immun. 59, 1984-1990..
23. Hollsing, A.E., Granstrom, M., Vasil, M.L., Wretlind, B. and Strandvik, B. (1987) Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J. Clin. Microbiol. 25, 1868-1874.
24. McClure, C.D. and Schiller, N.L. (1992) Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages. J. Leukocyte Biol. 51, 97-102.
25. Read, R.C., Roberts, P., Munro, N., Rutman, A., Hastie, A., Shryock, T., Hall, R., McDonald-Gibson, W., Lund, V., Taylor, G. et al. (1992) Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J. Appl. Physiol. 72, 2271-2277.
26. Cryz, S.J. Jr, Furer, E., Sadoff, J.C., Germanier, R., Pastan, I., Willingham, M.C. and FitzGerald, D.J. (1987) Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins. Rev. Infect. Dis. 9 (Suppl. 5), S644-S649.
27. Woods, D.E., To, M. and Sokol, P.A. (1989) Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infection. In: Pseudomonas aeruginosa infection (Høiby, N., Pedersen, S.S., Shand, G.H., Doring, G. and Holder, I.A., Eds.), Antibiot. Chemother. Vol. 42, pp. 27-35. Karger, Basel.
28. Kulich, S.M., Frank, D.W. and Barbieri, J.T. (1995) Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infect. Immun. 63, 1-8.
29. Sokol, P.A., Dennis, J.J., MacDougall, P.C., Sexton, M. and Woods, D.E. (1990) Cloning and expression of the Pseudomonas aeruginosa exoenzyme S toxin gene. Microb. Pathog. 8, 243-257.
30. Kulich, S.M., Yahr, T.L., Mende-Mueller, L.M., Barbieri, J.T. and Frank, D.W. (1994) Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388. J. Biol. Chem. 269, 10431-10437.
31. Homma, J.Y. and Tanimoto, H. (1988) A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and common protective antigen (OEP). Kitasato Arch. Exp. Med. 61, 81-93.
32. Homma, J.Y., Marihara, K., Toho, Y. and Kuhin, K. K. (1985) Toxoids of elastase of Pseudomonas aeruginosa. US Patent 4575-459, application 24.01.85. No. 694637, publication of 11.03.85. priority of 24.02.84 No. 59-35061. Japan. MKI, C07 G7/00, A61 K39/40, A61 k39/104, C12 P21/00, NKI 424/87.
33. Iglewski, B.H., Liu, P.V. and Kabat, D. (1977) Mechanism of action of Pseudomonas aeruginosa exotoxin A: adenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect. Immun. 15, 138-147.
34. Vasil, M.L., Kabat, D. and Iglewski, B.H. (1977) Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa. Infect. Immun. 16, 353-361.
35. Pollack, M. (1982) Pseudomonas toxin and toxoid. In: Bacterial Vaccines (Robbins, J.B., Hill, J.C. and Sadoff, J.C., Eds.), Vol. 4, pp. 64-68. Thieme-Stratton, New York.
36. Ogata, M., Chaudhary, V.K., Pastan, I. and FitzGerald, D.J. (1990) Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37 000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265, 20678-20685.
37. Bjorn, M.J., Iglewski, B.H., Ives, S.K., Sadoff, J.C. and Vasil, M.L. (1978) Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103. Infect. Immun. 19, 785-791.
38. Pollack, M. and Prescott, R.K. (1982) Toxoid from exotoxin A of Pseudomonas aeruginosa preparation and characterization. J. Infect. Dis. 145, 688-698.
39. Pavlovskis, O.R., Pollack, M., Callahan, L.T. III and Iglewski, B.H. (1977) Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infection. Infect. Immun. 18, 596-602.
40. Baskakova, N.M., Vertijev, Y.V., Moroz, A.F. and Mokrijevich, N.M. (1984) The preparation of P. aeruginosa exotoxin A and monospecific antitoxic serum. In: Specific Prophylaxis and Therapy in Opportunistic Microbial Infections (Moroz, A.F., Ed.), pp. 23-33. Publ. Medicina, Moscow (in Russian).
41. Ogaard, A.R. and Berdal, B.P. (1989) Pseudomonas aeruginosa extracellular toxicity in infant mice and the protective effect antitoxin A. APMIS 97, 475-478.
42. Sadoff, J.C., Buck, G.A., Iglewski, B.H., Bjorn, M. and Groman, N. (1982) Immunological cross-reactivity in the absence of DNA homology between Pseudomonas toxin A and diphtheria toxin. Infect. Immun. 37, 250-254.
43. Granstrom, M., Wretlind, B., Markman, B., Pavlovskis, O.R. and Vasil, M.L. (1985) Enzyme-linked Immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins. Eur. J. Clin. Microbiol. 4, 197-200.
44. Galloway, D.R., Hedstrom, R.C. and Pavlovskis, O.R. (1986) Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 44, 262-267.
45. Chia, J.K.S., Pollack, M., Avigan, D. and Steinbach, S. (1986) Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect. Immun. 52, 756-762.
46. Kroll, J.S. and Booy, R. (1996) Haemophilus influenzae: capsule vaccine and capsulation genetics. Mol. Med. Today 2, 160-165.
47. Sankilampi, U., Honkanen, P.O., Bloigu, A., Herva, E. and Leinonen, M. (1996) Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J. Infect. Dis. 173, 387-393.
48. Devi, S.J., Zollinger, W.D., Snoy, P.J., Tai, J.Y., Costantini, P., Norelli, F., Rappuoli, R. and Frasch, C.E. (1997) Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys. Infect. Immun. 65, 1045-1052.
49. Anderson, G.W. Jr., Leary, S.E., Williamson, E.D., Titball, R.W., Welkos, S.L., Worsham, P.L. and Friedlander, A.M. (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64, 4580-458.
50. Larsson, C., Stalhammar-Carlemalm, M. and Lindahl, G. (1996) Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha. Infect. Immun. 64, 3518-3523.
51. Stanislavsky, E.S. (1971) Bacterial Structures and its Antigenicity. Publ. Medicina, Moscow (in Russian).
52. Bartel, P.P., Orr, T.E. and Chudio, B. (1970) Purification and chemical composition of the protective slime antigen of Pseudomonas aeruginosa. Infect. Immun. 2, 543-549.
53. Zeidner, I.G., Palkina, N.A., Stanislavsky, E.S. and Landsman, N.M. (1981) Immunochemical analysis and protective properties of Pseudomonas aeruginosa slime component with different molecular weights. Zh. Microbiol. Epidemiol. Immunobiol. 4, 92-97 (in Russian, abstract in English).
54. Woods, D.E. and Bryans, L.E. (1985) Studies on the ability of alginate to act as protective immunogen against infection with Pseudomonas aeruginosa. J. Infect. Dis. 151, 581-588.
55. Linker, A. and Jones, R.S. (1966) A new polysaccharide resembling alginic acid isolated from pseudomonads. J. Biol. Chem. 241, 3845-3851.
56. DeVries, C.A. and Ohman, D.E. (1994) Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for auto-regulation. J. Bacteriol. 176, 6677-6687.
57. Goldberg, J.B., Gorman, W.L., Flynn, J.L. and Ohman, D.E. (1993) A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J. Bacteriol. 175, 1303-1308.
58. Bryan, L.E., Kureishl, A. and Rabins, H.R. (1983) Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18, 276-282.
59. Pedersen, S.S., Espersen, F., Høiby, N. and Shand, G.F. (1989) Purification, characterization and immunological cross-reactivity of alginates produced by mucoid strains of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 27, 691-699.
60. Cryz, S.J. Jr., Furer, E. and Que, J.U. (1991) Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine. Infect. Immun. 59, 45-50.
61. Sensacovic, J.W. and Bartell, P.F. (1975) Biological activity of fragments derived from the extracellular slime glycolipoprotein of Pseudomonas aeruginosa. Infect. Immun. 12, 808-812.
62. Nadaud, M. (1985) A new schema for additional typing of P. aeruginosa using antisera against glycopolypeptide derived from slime of the microorganisms. Zbl. Bakteriol. Hyg. A260, 71-80.
63. Stanislavsky, E.S., Kholodkova, E.V., Yushkova, N.A., Yourokova, I.B. and Zhvanetskaya, M.I. (1986) Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups. Acta Microbiol. Hung. 33, 55-67.
64. Youshkova, N.A., Kholodkova, E.V., Korobova, T.S. and Stanislavky, E.S. (1986) Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein. Acta Microbiol. Hung. 33, 147-156.
65. Pier, G.B. (1985) Pseudomonas aeruginosa surface polysaccharide vaccines. Antibiot. Chemother. 36, 157-167.
66. Pier, G.B. and Bennett, S.E. (1986) Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide. J. Clin. Invest. 77, 491-495.
67. Pier, G.B., DesJardin, D., Grout, M., Garner, C., Bennett, S.E., Pekoe, G., Fuller, S.A., Thornton, M.O., Harkonen, W.S. and Miller, H.C. (1994) Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect. Immun. 62, 3972-3979.
68. Duchesne, L.G.M., Lam, J.S., MacDonald, L.A., Whitfield, C. and Kropinski, A.M. (1988). Effect of pH and acrylamide concentration on the separation of lipopolysaccharides in polyacrylamide gels. Curr. Microbiol. 16, 191-194.
69. De Kievit, T.R., Dasgupta, T., Schweizer, H. and Lam, J.S. (1995) Molecular cloning and characterization of the rfc gene of Pseudomonas aeruginosa (serotype O5). Mol. Microbiol. 16, 565-574.
70. Habs, I. (1957) Untersuchungen über die O-Antigene von Pseudomonas aeruginosa. Z. Hyg. Infekt.-Kr. 144, 218-228.
71. Lanyi, B. (1966/1967) Serological properties of Pseudomonas aeruginosa. I. Group-specific somatic antigens. Acta Microbiol. Acad. Sci. Hung. 13, 295-318.
72. Sandvik, O. (1960) Serological comparison between strains of Pseudomonas aeruginosa from human animals sources. Acta Pathol. Microbiol. Scand. 48, 56-67.
73. Verder, E. and Evans, J. (1961) A proposed antigen schema for the identification of strains of Pseudomonas aeruginosa. J. Infect. Dis. 109, 183-193.
74. Meitert, T. (1964) Contribution a l'étude de la structure antigenéique des B. pyocyaniques. II. Individualisation des groupes sérologiques au moyen des antigènes 'O'. Arch. Roum. Pathol. Microbiol. 23, 679-692.
75. Akatova, N.S. and Smirnova, N.B. (1982) Serological classification of Pseudomonas aeruginosa. Zh. Microbiol. Epidemiol. Immunobiol. 7, 87-91.
76. Homma, Y. J. (1976) A new antigenic scheme and live cell slide agglutination procedure for the intrasubspecific, serologic classification of Pseudomonas aeruginosa. Jap. J. Exp. Med. 46, 329-336.
77. Wokatsch, R. (1964) Serologische Untersuchungen an Pseudomonas aeruginosa (Bact. Pyocyaneum) aus verschiedenen Tierarten. Zbl. Bakteriol. Abt. I. Orig. 192, 468-476.
78. Liu, P.V., Matsomoto, H., Kusama, H. and Bergan, T. (1983) Survey of heat-stable major somatic antigens of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 33, 256-275.
79. Lam, M.Y.C., MacDonald, L.A. and Lam, J.S. (1990) Characterization of LPS-specific monoclonal antibodies reactive with Pseudomonas aeruginosa serotypes 07/08/09. In: Cellular and Molecular Aspects of Endotoxin Reactions (Nowotny, A., Spitzer, J.J. and Ziegler, E.J., Eds.), pp. 339-346. Elsevier, Amsterdam.
80. Fisher, M.W., Delvin, H.R. and Gnabasik, F.J. (1969) New immunotype scheme for Pseudomonas aeruginosa. J. Bacteriol. 98, 835-836.
81. Pitt, T.L. and Erdman, Y.J. (1978) The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J. Med. Microbiol. 11, 15-23.
82. Rivera, M., Bryan, L.E., Hancock, R.E. and McGroarty, E.J. (1988) Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J. Bacteriol. 170, 512-521.
83. Lam, M.Y.C., McGroarty, E.J., Kropinski, A.M., MacDonald, L.A., Pedersen, S.S., Høiby, N. and Lam, J.S. (1989) Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J. Clin. Microbiol. 27, 962-967.
84. Stanislavsky, E.S., Makarenko, T.A., Kholodkova, E.V. and Lugowski, C. (1997) R-form lipopolysaccharides of Gram-negative bacteria as possible vaccine antigens. FEMS Immunol. Med. Microbiol. 18, 139-145.
85. Lam, J.S., MacDonald, L.A., Lam, M.Y.C., Duchesne, L.G.M. and Southam, G.G. (1987) Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55, 1051-1057.
86. Lam, J.S., MacDonald, L.A. and Lam, M.Y.C. (1987) Monoclonal antibody production against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55, 2854-2856.
87. Lam, J.S., MacDonald, L.A., Kropinski, A.M. and Speert, D.P. (1988) Characterization of nontypable strains of Pseudomonas aeruginosa from cystic fibrosis patients by means of monoclonal antibodies and SDS-polyacrylamide gel electrophoresis. Serodiag. Immunother. Infect. Dis. 2, 365-374.
88. Lanyi, B., Adam, M.M. and Szentmihalyi, A. (1975) Classification of Pseudomonas aeruginosa O-antigens by immunoelectrophoresis. J. Med. Microbiol. 8, 225-233.
89. Adam, M.M., Kontrohr, T. and Horvath, E. (1971) Serological studies on Pseudomonas aeruginosa O group lipopolysaccharides. Acta Microbiol. Acad. Sci. Hung. 18, 307-312.
90. Wilkinson, S.G. (1983) Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa. Rev. Infect. Dis. 5 (Suppl. 5), S941-S949.
91. Masoud, M., Sadovskaya, I., de Kievit, T., Altman, E., Richards, J.C. and Lam, J.S. (1995) Structural elucidation of the LPS core region of the O-chain deficient mutant strain A28 from Pseudomonas aeruginosa serotype O6 (IATS). J. Bacteriol. 177, 6718-6726.
92. Masoud, H., Altman, E., Richards, J.C. and Lam, J.S. (1994). A general strategy for structural analysis of the oligosaccharide region of lipopolysaccharides. Structure of oligosaccharide component of Pseudomonas aeruginosa IATS serotype O6 mutant R5 rough-type lipopolysaccharide. Biochemistry 33, 10568-10578.
93. Beckmann, F., Moll, H., Jäger, K.-E. and Zähringer, U. (1995) Preliminary communication, 7-O-carbamoyl-L-glycerol-D-manno-heptose: a new core constituent in the lipopolysaccharide of Pseudomonas aeruginosa. Carbohydr. Res. 267, C3-C7.
94. Altman, E., Sadovskaya, I., Lam, J.S. and Richards, J.C. (1993) Structural analysis of the Pseudomonas aeruginosa IATS O5 lipopolysaccharide core oligosaccharide. Fourth International Symposium on Pseudomonas: Biotechnology and Molecular Biology, Vancouver, B.C., Abstr. 29.
95. Hanession, S., Reagen, D., Watson, D. and Haskell, T.H. (1971) Isolation and characterization of antigens of a new heptavalent Pseudomonas vaccine. Nature New Biol. 229, 209-215.
96. Adam, M.M. and Kontrohr, T. (1971) Pseudomonas aeruginosa O-gsport lipopolizaccharidic cukor oszetevoi. Proc. 12th Meeting of the Hungarian Society of Biochemistry, Pecs, Hung. Soc. Biochem., Budapest, pp. 57-261.
97. Chester, I.R., Meadow, P.W. and Pitt, T.L. (1973) The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serogroups. J. Gen. Microbiol. 78, 305-318.
98. Wilkinson, S.G. and Galbraith, L. (1975) Studies of lipopolysaccharides from Pseudomonas aeruginosa. Eur. J. Biochem. 52, 331-343.
99. Koval, S.F. and Meadow, P.W. (1975) The relationship between aminosugars in the lipopolysaccharide serotype and aeruginocin sensitivity in strains of Pseudomonas aeruginosa. J. Gen. Microbiol. 91, 437-440.
100. Suzuki, N., Tsunemaysu, Y., Matsumoto, H. and Tazaki, T. (1977) Relationship between Habs serotypes and 2-amino sugar composition of Pseudomonas aeruginosa. Infect. Immun. 15, 692-711.
101. Wilkinson, S.G. (1977) Amino acid components of the lipopolysaccharide from Pseudomonas aeruginosa N.C.T.C. 8505. Biochem. J. 161, 103-116.
102. Horton, D., Rodemeyer, G. and Haskell, T.H. (1977) Analytical characterization of lipopolysaccharide antigens from seven strains of Pseudomonas aeruginosa. Carbohydrate Res. 55, 35-49.
103. Knirel, Y.A., Vinogradov, E.V., Kocharova, N.A., Paramonov, N.A., Kochetkov, N.K., Dmitriev, B.A., Stanislavsky, E.S. and Lanyi, B. (1988) The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa. Acta Microbiol. Hung. 35, 3-24.
104. Kenne, L. and Lindberg, B. (1985) Bacterial polysaccharides. In: The Polysaccharides (Aspinall, G.O., Ed.), Vol. 2, pp. 287-363. Academic Press, New York.
105. Stanislavsky, E.S., Lanyi, B., Knirel, Y.A. and Dmitriev, B.A. (1988) Chemotypes of Pseudomonas aeruginosa. Zh. Microbiol. Epidemiol. Immunobiol. 5, 10-14 (in Russian, abstract in English).
106. Chaplinsky, V.Y., Akatova, N.S., Trostan, L.N. (1984) The characterization of Pseudomonas aeruginosa O-antigens, serogroup O2. Zh. Microbiol. Epidemiol. Immunobiol. 6, 109 (in Russian, abstract in English).
107. Cryz, S.J. Jr., Sadoff, J.C. and Furer, E. (1989) Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Microb. Pathog. 6, 75-80.
108. Cryz, S.J. Jr., Sadoff, J.C. and Furer, E. (1988) Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans. Infect. Immun. 56, 1829-1830.
109. Kocharova, N.A., Knirel, Y.A., Stanislavsky, E.S., Kholodkova, E.V., Lugowski, C., Jachymek, W. and Romanowska, E. (1996) Structural and serological studies of lipopolysaccharides of Citrobacter O35 and O38 antigenically related to Salmonella. FEMS Immunol. Med. Microbiol. 13, 1-8.
110. Vinogradov, E.V., Knirel, Y.A., Lipkind, G.M., Shashkov, A.S., Kochetkov, N.K., Stanislavsky, E.S. and Kholodkova, E.V. (1987) Antigenic polysaccharides of bacteria. 23. Structure of the O-specific polysaccharide chain of Salmonella arizonae O59 lipopolysaccharide. Biorg. Khim. 13, 1275-1281 (in Russian, abstract in English).
111. Drewry, D.T., Symes, K.C., Gray, K.C. and Wilkinson, S.G. (1975) Studies of polysaccharide fractions from the lipopolysaccharide of Pseudomonas aeruginosa N.C.T.C. 1999. Biochem. J. 149, 93-106.
112. Rowe, P.S.N. and Meadow, P.W. (1983) Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. Eur. J. Biochem. 132, 329-337.
113. Ziegler, E.J. (1988) Protective antibody to endotoxin core: the emperor's new clothes? J. Infect. Dis. 158, 286-290.
114. De Kievit, T.R. and Lam, J.S. (1994) Monoclonal antibodies that distinguish inner core, outer core and lipid A regions of Pseudomonas aeruginosa lipopolysaccharides. J. Bacteriol. 176, 7129-7139.
115. Yokota, S., Ochi, H., Ohtsuka, H., Kato, M. and Noguchi, H. (1989) Heterogeneity of the L-rhamnose residue in the outer core of Pseudomonas aeruginosa lipopolysaccharide, characterized by using human monoclonal antibodies. Infect. Immun. 57, 1691-1696.
116. Terashima, M., Uezumi, K., Tomio, T., Kato, M. and Noguchi, H. (1991) Protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infect. Immun. 59, 1-6.
117. Yokota, S., Kaya, S., Sawada, S., Kawamura, T., Araki, Y. and Ito, E. (1987) Characterization of a polysaccharide component of lipopolysaccharide from Pseudomonas aeruginosa IID 1008 (ATCC 27584) as D-rhamnan. Eur. J. Biochem. 167, 203-209.
118. Collins, M.S., Ladehoff, D.K., Mehton, N.S. and Noonan, J.S. (1990) Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa. FEMS Microbiol. Immunol. 64, 263-268.
119. Luderitz, O., Galanos, C., Lehman, V., Mayer, H., Rietschel, E.T. and Weckesser, J. (1978) Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften 65, 578-585.
120. Luderitz, O., Freudenberg, M.A., Galanos, C., Lehmann, V., Rietschel, E.T. and Shaw, D.H. (1982) Lipopolysaccharides of Gram-negative bacteria. In: Current Topics in Membranes and Transport, Vol. 17, pp. 79-151. Academic Press, London.
121. Kulshin, V.A., Zahringer, U., Linder, B., Jager, K.-E., Dmitriev, B.A. and Rietschel, E.T. (1991) Structure characterization of lipid A component of Pseudomonas aeruginosa wild type and rough mutant lipopolysaccharides. Eur. J. Biochem. 198, 697-704.
122. Bhat, R., Marx, A., Galanos, C. and Conrad, R. (1990) Structural studies of lipid A from Pseudomonas aeruginosa PAO1: Occurrence of 4-amino-4-deoxyarabinose. J. Bacteriol. 172, 6631-6636.
123. Karunaratne, D.N., Richards, J.C. and Hancock, R.E. (1992) Characterization of lipid A from Pseudomonas aeruginosa O-antigenic B band lipopolysaccharide by 1D and 2D NMR and mass spectral analysis. Arch. Biochem. Biophys. 299, 368-76.
124. Ziegler, E.J., Teng, N.N.H., Douglas, H., Wunderlich, A., Berger, H.J. and Bolmer, S.D. (1987) Treatment of pseudomonas bacteremia in neutropenic rabbits with human monoclonal IgM antibody against Escherichia coli lipid A. Clin. Res. 35, 619A.
125. Marget, W. (1987) Lipid A - Antikörpertiter beim Menschen. Infektion 115, 142-145.
126. Stanislavsky, E.S., Makarenko, T.A. and Kozenova, T.E. (1992) Specific and non-specific mouse protection induced by different chemotypes of Pseudomonas aeruginosa lipopolysaccharides. FEMS Microbiol. Immunol. 105, 181-190.
127. Lam, J.S., Graham, L.L., Lightfoot, J., Dasgupta, T. and Beveridge, T.J. (1992) Ultrastructural examination of the lipopolysaccharide of Pseudomonas aeruginosa strains and their isogenic rough mutants by freeze substitution. J. Bacteriol. 174, 7159-7167.
128. Janson, P.E., Linberg, A.A., Linberg, B. and Wolin, R. (1981) Structural studies on the hexose region on the core lipopolysaccharides from Enterobacteriaceae. Eur. J. Biochem. 115, 571-577.
129. Marx, A., Meitert, E., Salagenau, A., Olinesku, A., Savulian, C., Sima, F. and Chersulick, E. (1987) Specific and non-specific protection of mice with Pseudomonas aeruginosa lipopolysaccharides. Zbl. Bakteriol. Mikrobiol. Hyg. A264, 154-162.
130. Cryz, S.J., Furer, E., Meadow, P.M. and Germanier, R. (1985) Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides. Eur. J. Clin. Microbiol. 4, 180-185.
131. Stanislavsky, E.S., Makarenko, T.A., Kholodkova. E.V. and Suhachevska, M.V. (1995) Mouse protection induced Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re mutant and Escherichia coli O14. FEMS Immunol. Med. Microbiol. 11, 81-86.
132. Sawada, S., Kawamura, T., Masuho, Y. and Tomibe, K. (1985) A new common polysaccharide antigen of strains of Pseudomonas aeruginosa detected with a monoclonal antibodies. J. Infect. Dis. 152, 1290-1299.
133. Kocharova, N.A., Knirel, Y.A., Kochetkov, N.K. and Stanislavsky, E.S. (1988) Characterization of a rhamnan derived from preparations of Pseudomonas aeruginosa lipopolysaccharides. Bioorg. Khim. 14, 701-703 (in Russian, abstract in English).
134. Kocharova, N.A., Hatano, K., Shashkov, A.S., Knirel, Y.A., Kochetkov, N.K. and Pier, G.B. (1989) The structure and serologic distribution of extracellular neutral polysaccharide from Pseudomonas aeruginosa immunotype 3. J. Biol. Chem. 264, 15569-15573.
135. Kocharova, N.A., Knirel, Y.A., Romanowska, A., Romanovska, E., Makarenko, T.A., Edvabnaya, L.S., Stanislavsky, E.S., Zdorovenko, G.M. and Yakovleva, L.M. (1991) Detection of a common polysaccharide antigen of Pseudomonas aeruginosa with O-antiserum to P. cerasi. FEMS Microbiol. Immunol. 76, 69-74.
136. Knirel, Y.A., Kocharova, N.A., Shashkov, A.S., Dmitriev, B.A., Kochetkov, N.K., Stanislavsky, E.S. and Mashilova, G.M. (1987) Somatic antigens of Pseudomonas aeruginosa. The structure of O-specific polysaccharide chains of the lipopolysaccharides from Pseudomonas aeruginosa O5 (Lanyi) and immunotype 6 (Fisher) Eur. J. Biochem. 167, 639-652.
137. Rivera, M., Chivers, T.R., Lam, J.S. and McGroarty, E.J. (1992) Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7. J. Bacteriol. 174, 2407-2411.
138. Currie, H.L., Lightfoot, J. and Lam, J.S. (1995) Prevalence of gca, a gene involved in synthesis of A-band common antigen polysaccharide in Pseudomonas aeruginosa. Clin. Diagn. Lab. Immunol. 2, 554-562.
139. Arsenault, T.L., Hughes, D.W., MacLean, D.B., Szarek, W.A., Kropinski, A.M.B. and Lam, J.S. (1991) Structural studies on the polysaccharide portion of 'A-band' lipopolysaccharide from a mutant (AK1401) of Pseudomonas aeruginosa strain PAO1. Can. J. Chem. 69, 1273-1280.
140. Makarenko, T.A., Kocharova, N.A., Edvabnaya, L.S., Tsvetkov, Y.E., Kholodkova, E.V., Knirel, Y.A., Backinovsky, L.V., Kochetkov, N.K. and Stanislavsky, E.S. (1993) Immunological studies of an artificial antigen with specificity of a common polysaccharide antigen of Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 7, 251-256.
141. Nikaido, H. (1992) Nonspecific and specific permeation channels of Pseudomonas aeruginosa outer membrane. In: Pseudomonas. Molecular Biology and Biotechnology (Gali, E., Silver, S. and Witholt, B., Eds.), pp. 146-153. Am. Soc. Microbiol., Washington, DC.
142. Nikaido, H. (1992) Porins and specific channels of bacterial outer membranes. Mol. Microbiol. 6, 435-442.
143. Hancock, R.E.W., Siehnel, R. and Martin, N. (1990) Outer membrane proteins of Pseudomonas. Mol. Microbiol. 4, 1069-1075.
144. Bally, M., Wretlind, B. and Lazdunski, A. (1989) Protein secretion in Pseudomonas aeruginosa: molecular cloning and characterization of the xcp-1 gene. J. Bacteriol. 171, 4342-4348.
145. Bell, A. and Hancock, R.E.W. (1989) Outer membrane protein H1 of Pseudomonas aeruginosa: purification of the protein and cloning and nucleotide sequence of the gene. J. Bacteriol. 171, 3211-3217.
146. Benz, R. and Hancock, R.E.W. (1987) Mechanism of ion transport through the anion-selective channel of the Pseudomonas aeruginosa outer membrane. J. Gen. Physiol. 89, 275-295.
147. Cox, C.D. (1985) Iron transport and serum resistance in Pseudomonas aeruginosa. Antibiot. Chemother. 36, 1-12.
148. Heinrichs, D.E. Young, L. and Poole, K. (1991) Pyochelin-mediated iron transport in Pseudomonas aeruginosa: involvement of a high-molecular-mass outer membrane protein. Infect. Immun. 59, 3680-3684.
149. Sokol, P.A. and Woods, D.E. (1983) Demonstration of an iron-siderophore-binding protein in the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 40, 665-669.
150. Yoshihara, E. and Nakae, T. (1989) Identification of porins in outer membrane of Pseudomonas aeruginosa that form small diffusion pores. J. Biol. Chem. 264, 6297-6301.
151. Ohkawa, I., Shiga, S. and Kageyama, M. (1979) An esterase on the outer membrane of Pseudomonas aeruginosa for the heterolysis of long chain acyl esters. J. Biochem. (Tokyo) 86, 643-656.
152. Poole, K. and Hancock, R.E.W. (1986) Isolation of a Tn501 insertion mutant lacking porin protein P of Pseudomonas aeruginosa. Mol. Gen. Genet. 202, 403-409.
153. Trias, J., Rosenberg, E.Y. and Nikaido, H. (1988) Specificity of the glucose channel formed by protein D1 of Pseudomonas aeruginosa. Biochim. Biophys. Acta 938, 493-496.
154. Angus, B.I. and Hancock, R.E.W. (1983) Outer membrane porin proteins F, P and D of Pseudomonas aeruginosa and PhoE of Escherichia coli chemical cross-linking to reveal native oligomers. J. Bacteriol. 155, 1042-1051.
155. Weger, L.A., Boxtel, R. and Burg, B. (1986) Siderophores and outer membrane proteins of antagonistic, plant-growth-stimulating, root-colonizing Pseudomonas spp. J. Bacteriol. 165, 585-594.
156. Bascher, K.H., Cullmann, W., Dick, W. and Opferkuch, W. (1987) Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob. Agents Chemother. 31, 703-708.
157. Quinn, J.P., Dudek, E. J., DiVincenzo, C.A., Lucks, D.A. and Lerner, S.A. (1986) Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infection. J. Infect. Dis. 154, 289-294.
158. Trias, J. and Nikaido, H. (1990) Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J. Biol. Chem. 265, 15680-15684.
159. Hancock, R.E.W. and Carey, A.M. (1979) Outer membrane of Pseudomonas aeruginosa: heat and 2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140, 902-912.
160. Yoshimura, F., Zalman, L.S. and Nikaido, H. (1983) Purification and properties of Pseudomonas aeruginosa porin. J. Biol. Chem. 258, 2308-2314.
161. Woodruff, W. A. and Hancock, R.E.W. (1989) Pseudomonas aeruginosa outer membrane protein F: structural role and relationship to the Escherichia coli OmpA protein. J. Bacteriol. 171, 3304-3309.
162. Yates, J.M., Morris, G. and Brown, M.R. (1989) Effect of iron concentration and growth rate on the expression of protein G in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 89, 259-262.
163. Nicas, T.I. and Hancock, R.E.W. (1980) Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B and gentamicin. J. Bacteriol. 143, 872-878.
164. Hancock, R.E.W., Irvin, R.T., Costerton, J.W. and Carey, A.M. (1981) Pseudomonas aeruginosa outer membrane: peptidoglycan-associated proteins. J. Bacteriol. 145, 628-631.
165. Duchesne, M., Barron, C., Schweizer, A., von Specht, B. and Domdey, H. (1989) Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence and expression in Escherichia coli. J. Bacteriol. 171, 4130-4137.
166. Finke, M., Duchene, M., Eckhardt, A., Domdey, H. and von Specht, B. (1990) Protection against experimental Pseudomonas aeruginosa lipoprotein I expressed in Escherichia coli. Infect. Immun. 58, 2241-2244.
167. Hirai, K., Susue, S., Irakura, T., Iyobe, S. and Mitsuhashi, S. (1987) Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 31, 582-586.
168. Wretlind, B. and Pavlovskis, O.R. (1984) Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteins. J. Bacteriol. 158, 801-808.
169. Makarenko, T.A. and Stanislavsky, E.S. (1996) Immunological study of Pseudomonas aeruginosa cell wall proteins. J. Microbiol. Epidemiol. Immunol. 2, 7-9 (in Russian, abstract in English).
170. Chekan, L.V., Stanislavsky, E.S. and Palkina, N.A. (1983) Cell-free Pseudomonas aeruginosa vaccine. Commun. 3. Immunological analysis of purified Pseudomonas aeruginosa protein antigens and the protective properties of antisera to these antigens. Zh. Microbiol. Epidemiol. Immunobiol. 2, 92-96 (in Russian, abstract in English).
171. Homma, Y.J. (1975) Pseudomonas aeruginosa infection and its serodiagnosis. In: Microbial Drug Resistance (Mitsuhashi, S. and Hashimoto, H., Eds.), pp. 267-281. University of Tokyo Press, Tokyo.
172. Abe, C., Shionoya, H., Hirao, K. and Homma, Y.J. (1975) Common protective antigen (OEP) of Pseudomonas aeruginosa. Jpn. J. Exp. Med. 45, 355-359.
173. Shimizu, T., Homma, Y.J., Abe, C., Tanamoto, K., Aoyama, Y., Okada, K., Yanagawa, R., Fujimoto, Y., Noda, H., Takashima, I., Honda, E. and Minanide, S. (1976) Effect of common protective antigen (OEP) vaccination to protect mink from challenge exposure with Pseudomonas aeruginosa. Am. J. Vet. Res. 37, 1441-1452.
174. Chekan, L.V. and Stanislavsky, E.S. (1980) Immunological analysis water-soluble antigenic complexes isolated from Pseudomonas aeruginosa typing strains of different O-serogroups. Zh. Microbiol. Epidemiol. Immunobiol. 12, 49-54 (in Russian, abstract in English).
175. Sompolinsky, D., Hertz, J., Høiby, N., Jensen, K., Mansa, B. and Samra, Z. (1980) An antigen common to a wide range of bacteria. I. The isolation of a common antigen from Pseudomonas aeruginosa. Acta Pathol. Microbiol. Scand. Sect. B 88, 143-149.
176. Stanislavsky, E.S., Edvabnaya, L.S., Zaidner, I.G., Makarenko, T.A., Bulk, V.F., Zhvanetskaya, M.I. and Mashilova, G.M. (1986) Immunochemical and immunological study of cell-wall proteins of Pseudomonas aeruginosa. Acta Microbiol. Hung. 33, 245-255.
177. Gilleland, H.E., Parker, M.G., Matthews, J.M. and Berg, R.D. (1984) Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect. Immun. 44, 49-54.
178. Gilleland, H.E., Gilleland, L.B. and Matthews-Greer, J.M. (1988) Outer membrane protein F preparation of Pseudomonas aeruginosa as vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect. Immun. 5, 1017-1022.
179. Park, W.J., Cho, Y.J., Ahn, D.H., Kim, Y.G., Kim, H.S., Hahm, K.-S. and Kim, Y.S. (1995) Purification and protective effect of porin protein F from Pseudomonas aeruginosa. Microorg. Ind. (Seoul) 21, 100-106 (in Korean, abstract in English).
180. Joo, I., Stanislavsky, E.S., Zhvanetskaya, M. I., Mashilova, G.M. and Gladus, M.A. (1982) Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines. Acta Microbiol. Acad. Sci. Hung. 29, 267-275.
181. Stanislavsky, E.S., Edvabnaya, L.S., Bandman, O.A., Boolk, V.F., Zhvanetskaya, M.I. and Vargina, A.K. (1989) Experimental studies on the protective efficacy of a Pseudomonas aeruginosa vaccine. Vaccine 7, 562-566.
182. Stanislavsky, E.S., Balayan, S.S., Sergienko, A.I., Makarenko, T.A., Edvabnaya, L.S., Krohina, M.A. and Rusanov, V.M. (1991) Clinical-immunological trials of Pseudomonas aeruginosa vaccine. Vaccine 9, 491-494.
183. Park, W.J., Cho, Y.J., Kim, Y.G., Kim, J.-H., Park, K.H., Kim, Y.S. and Hahm, K.-S. (1994) Active and passive protective effect of CFC-101 (Pseudomonas vaccine) in mice. J. Appl. Pharmacol. (Seoul) 2, 326-330 (in Korean, abstract in English).
184. Lanyi, B. (1970) Serological properties of Pseudomonas aeruginosa. II. Type-specific thermolabile (flagellar) antigens. Acta Microbiol. Acad. Sci. Hung. 17, 35-48.
185. Ansorg, R. (1978) Flagella specific H antigen schema of Pseudomonas aeruginosa. Zbl. Bakteriol. A242, 228-239.
186. Pitt, T.L. (1981) The antibody response to the flagella of Pseudomonas aeruginosa. J. Med. Microbiol. 14, 261-270.
187. Montie, T.C., Craven, R. and Holder, I.A. (1982) Flagella preparation from Pseudomonas aeruginosa: isolation and characterization. Infect. Immun. 35, 281-288.
188. Drake, D. and Montie, T.C. (1987) Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagella serum. Can. J. Microbiol. 33, 755-763.
189. Rosok, M.J., Stebbins, M.R., Connelly, K., Lostrom, M.E. and Siadak, A.W. (1990) Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa. Infect. Immun. 58, 3819-3828.
190. Spangenberg, C., Heuer, T., Bürger, C. and Tümmler, B. (1996) Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett. 396, 213-217.
191. Bradley, D.E. (1966) The structure and infective process of a Pseudomonas aeruginosa bacteriophage containing ribonucleic acid. J. Gen. Microbiol. 45, 83-96.
192. Bradley, D.E. and Pitt, T.L. (1975) Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J. Gen. Virol. 23, 1-15.
193. Bradley, D.E. (1974) The adsorption of Pseudomonas aeruginosa pilus-dependent bacteriophages to a host mutant with nonretractile pili. Virology 58, 149-163.
194. Pasloske, B.L., Finlay, B.B. and Paranchych, W. (1985) Cloning and sequencing of the Pseudomonas aeruginosa PAK pilin gene. FEBS Lett. 183, 408-412.
195. Folkhard, W., Marvin, D.A., Watts, T.H. and Paranchych, W. (1981) Structure of polar pili from Pseudomonas aeruginosa strains K and O. J. Mol. Biol. 149, 79-93.
196. Watts, T.H., Kay, C.M. and Paranchych, W. (1983) Spectral properties of three quaternary arrangements of Pseudomonas pilin. Biochemistry 22, 3640-3646.
197. Paranchych, W., Pasloske, B.L. and Sastry, P.A. (1990) Expression, processing, and assembly of Pseudomonas aeruginosa N-methylphenylalanine pilin. In: Pseudomonas - Biotransformations, Pathogenesis and Evolving Biotechnology (Silver, S., Chakrabarty, A.M., Igleswski, B. and Kaplan, S., Eds.), pp. 343-351. Am. Soc. Microbiol., Washington, DC.
198. Lee, K.K., Sheth, H.B., Wong, W.Y., Sherburne, R., Paranchych, W., Hodges, R.S., Lingwood, C.A., Krivan, H. and Irvin, R.T. (1994) The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol. Microbiol. 11, 705-713.
199. Farinha, M.A., Conway, B.D., Glasier, L.M., Ellert, N.W., Irvin, R.T., Sherburne, R. and Paranchych, W. (1994) Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice. Infect. Immun. 62, 4118-4123.
200. Wong, W.Y., Campbell, A.P., McInnes, C., Sykes, B.D., Paranchych, W., Irvin, R.T. and Hodges, R.S. (1995) Structure-function analysis of the adherence-binding domain on the pilin of Pseudomonas aeruginosa strains PAK and KB7. Biochemistry 34, 2963-12972.
201. Chao, H., Houston, M.E. Jr., Grothe, S., Kay, C.M., O'Connor-McCourt, M., Irvin, R.T. and Hodges, R.S. (1996) Kinetic study on the formation of a de novo designed heterodimeric coiled-coil: use of surface plasmon resonance to monitor the association and dissociation of polypeptide chains. Biochemistry 35, 12175-12185.
202. Pitt, T.L. and Bradley, D.E. (1975) The antibody response to the flagella of Pseudomonas aeruginosa. J. Med. Microbiol. 8, 97-106.
203. Bradley, D.E. and Pitt, T.L. (1974) Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J. Gen. Virol. 23, 1-10.
204. Buchanan, T.M. and Pearce, W.A. (1976) Pili as a mediator of the attachment of gonococci to human erythrocytes. Infect. Immun. 13, 1483-1492.
205. Woods, D.E., Straus, D.C., Johanson, W.G. Jr., Berry, V.K. and Bass, J.A. (1980) Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect. Immun. 29, 1146-1151.
206. Ivanova, T.V., Bandman, O.A., Salov, V.F., Sakayan, N.N., Smolanskaya, A.Z. and Stanislavsky, E.S. (1988) Characterization of Pseudomonas aeruginosa pili and their relationship to virulence. Zh. Microbiol. Epidemiol. Immunobiol. 10, 3-6 (in Russian, abstract in English).
207. Pier, G.B., Grout, M., Zaidi, T.S., Olsen, J.C., Johnson, L.G., Yankaskas, J.R. and Goldberg, J.B. (1996) Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67.
208. Zaidi, T.S., Fleiszig, S.M., Preston, M.J., Goldberg, J.B. and Pier, G.B. (1996) Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 37, 976-986.
209. Lieberman, M.M. (1978) Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity. Infect. Immun. 21, 76-86.
210. Lieberman, M.M. and Ayala, E. (1983) Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice. J. Immunol. 131, 1-3.
211. Gonggrijp, R., Mullers, W.J. and van Boven, C.P. (1981) Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa. Infect. Immun. 33, 178-85.
212. Gonggrijp, R., Volleberg, M.P., Lemmens, P.J. and van Boven, C.P. (1981) Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa. Infect. Immun. 31, 896-905.
213. Nunn, D., Bergman, S. and Lory, S. (1990) Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili. J. Bacteriol. 172, 2911-2919.
214. Nunn, D. and Lory, S. (1991) Product of the Pseudomonas aeruginosa gene pilD is a prepilin leader peptidase. Proc. Natl. Acad. Sci. USA 88, 3281-3285.
215. Cryz, S.J., Sadoff, J.C. and Furer, E. (1989) Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Microb. Pathog. 6, 75-80.
216. Schreiber, J.R., Nixon, K.L., Tosi, M.F., Pier, G.B. and Patawaran, M.B. (1991) Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J. Immunol. 146, 188-193.
217. von Specht, B., Knapp, B., Hungerer, K., Lucking, C., Schmitt, A. and Domdey, H. (1996) Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates. J. Biotechnol. 44, 145-153.
218. Gilleland, L.B. and Gilleland, H.E. (1995) Synthetic peptides representing 2 protective, linear B-cell epitopes of outer-membrane protein-F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific. Infect. Immun. 63, 2347-2351.
219. Kermani, P., Peloquin, L. and Lagace, J. (1995) Production of ScFv antibody fragments following immunization with a phage-displayed fusion protein and analysis of reactivity to surface-exposed epitopes of the protein F of Pseudomonas aeruginosa by cytofluorometry. Hybridoma 14, 323-328.
220. Tout, N.L. and Lam, J.S. (1997) Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Clin. Diagn. Lab. Immunol. 4, 147-155.
221. Emara, M., Malburg, S. and Lam, J.S. (1995) Expression of an anti-Pseudomonas aeruginosa lipopolysaccharide core recombinant antibody in Escherichia coli. J. Endotoxin Res. 2, 53-61.
222. Wang, J., Lory, S., Ramphal, R. and Jin, S. (1996) Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22, 1005-1012.
223. Wang, J., Mushegian, A., Lory, S. and Jin, S. (1996) Large-scale isolation of candidate virulence genes of Pseudomonas aeruginosa by in vivo selection. Proc. Natl. Acad. Sci. USA 93, 10434-10439.
224. Mahan, M.J., Slauch, J.M. and Mekalanos, J.J. (1993) Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259, 686-688.
225. Cryz, S.J. Jr., Pitt, T.L., Furer, E. and Germanier, R. (1984) Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44, 508-513.
226. Tang, H.B., DiMango, E., Bryan, R., Gambello, M., Iglewski, B.H., Goldberg, J.B. and Prince, A. (1996) Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64, 37-43.
227. Hancock, R.E.W., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P. and Pier, G.B. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42, 170-177.
228. Dasgupta, T., de Kievit, T.R., Masoud, H., Altman, E., Richards, J.C., Sadovskaya, I., Speert, D.P. and Lam, J.S. (1994) Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, O6. Infect. Immun. 62, 809-817.
229. Burrows, L.L., Charter, D.F. and Lam, J.S. (1996) Molecular characterization of the Pseudomonas aeruginosa serotype O5 B-band lipopolysaccharide gene cluster. Mol. Microbiol. 22, 481-495.
230. Burrows, L.L., Chow, D. and Lam, J.S. (1997) Pseudomonas aeruginosa B-band O-antigen chain length is modulated by Wzz (Rol). J. Bacteriol. 179, 1482-1489.
231. Reeves, P.R., Hobbs, M., Valvano, M.A., Skurnik, M., Whitfield, C., Coplin, D., Kido, N., Klena, J., Maskell, D., Raetz, C.R. and Rick, P.D. (1996) Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 4, 495-503.
232. Latifi, A., Winson, M.K., Foglino, M., Bycroft, B.W., Stewart, G.S., Lazdunski, A. and Williams, P. (1995) Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 17, 333-343.
233. Brint, J.M. and Ohman, D.E. (1995) Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of Rh1R-Rh1I, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J. Bacteriol. 177, 7155-7163.
234. Passador, L., Tucker, K.D. Guertin, K.R., Journet, M.P., Kende, A.S. and Iglewski, B.H. (1996) Functional analysis of the Pseudomonas aeruginosa autoinducer PAI. J. Bacteriol. 178, 5995-6000.